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Radiotherapy of squamous cell cancer metastases
from unknown primary site to neck lymph nodes
Wojciech Sàsiadek, Krzysztof Sk∏adowski, Andrzej Wygoda
Anna Mucha, Boles∏aw Pilecki, Mariusz Sygu∏a
A i m.  Metastases to neck lymph nodes are frequently the first symptoms of cancers arising in head and neck anatomical re-
gion (30-40%). In a some of those cases (c. 5%) the primary site remains unknown. The aim of this paper was to evaluate re-
sults of radiotherapy for neck lymph nodes metastases from an unknown primary site.
M a t e r i a l a n d  m e t h o d s.  Thirty six patients with squamous cell carcinoma cervical nodes metastases from unknown pri-
mary site were treated between 1980-1995 in the Maria Sk∏odowska-Curie Memorial Institute of Oncology in Gliwice. Eigh-
teen patients (50%) underwent combined therapy (surgery with postoperative radiotherapy), 16 (44.5%) underwent radiothe-
rapy alone and only 2 patients were treated with surgery alone. Surgical treatment consisted of tumorectomy (90%), only 10%
of patients underwent uni-or bilateral radical lymph node dissection. Total radiation doses for radiotherapy alone ranged from
30 Gy to 76 Gy, and postoperatively – from 20 Gy to 60 Gy.
R e s u l t s.  3-years disease free survival (DFS) rates were 45% in combined treatment group and 20% in group receiving ra-
diation therapy alone (p=0.028). After a median follow up of 39 months, 10 primary tumours were discovered – 8 in head and
neck regio and 2 in lower respiratory tracts. 3-years DFS rate in group with discovered primary tumours was 46%, while other
patients – 33% of 3 years DFS.
C o n c l u s i o n s.  Our results suggest the need for complementary, elective irradiation of the neck lymph nodes, as well as the
entire pharynx, postoperatively.
Ocena skutecznoÊci leczenia promieniami przerzutów raka p∏askonab∏onkowego
z nieznanego ogniska pierwotnego do w´z∏ów ch∏onnych szyi
W p r o w a d z e n i e.  Przerzuty do w´z∏ów ch∏onnych szyi sà cz´sto pierwszym objawem nowotworów rozwijajàcych si´ w tym
regionie anatomicznym (30-40%). ZnajomoÊç topografii sp∏ywu ch∏onki z narzàdów regionu g∏owy i szyi, jak i klinicznych ob-
jawów guzów, rozwijajàcych si´ w tym regionie anatomicznym, jak i nowotworów o innych lokalizacjach, znacznie u∏atwia wy-
krycie ogniska pierwotnego raka. Jednak˝e w niewielkim odsetku przypadków (oko∏o 5% wszystkich rozpoznaƒ przerzutów do
w´z∏ów ch∏onnych), pomimo przeprowadzonej dok∏adnej diagnostyki, niemo˝liwe jest znalezienie ogniska pierwotnego. Ce-
lem niniejszej pracy by∏a ocena wyników radioterapii w takich przypadkach.
M a t e r i a ∏  i  m e t o d y.  Analizie poddano grup´ 36 chorych, leczonych w Instytucie Onkologii w Gliwicach w latach 1980-
-1995, z powodu przerzutów raka p∏askonab∏onkowego do w´z∏ów ch∏onnych szyi z nieznanego ogniska pierwotnego. Pierw-
szym objawem choroby w grupie 33 m´˝czyzn i 3 kobiet w wieku od 26 do 85 lat (mediana 56,5) by∏y powi´kszone w´z∏y ch∏on-
ne szyi. U 18 (50%) chorych zastosowano skojarzonà metod´ leczenia (chirurgia z pooperacyjnà radioterapià), 16 (44,5%)
leczonych by∏o samodzielnym napromienianiem. Jedynie u dwóch chorych wykonano wy∏àcznie zabieg operacyjny. W wi´k-
szoÊci przypadków leczenie chirurgiczne polega∏o na wy∏uszczeniu guza (90%), jedynie u 10% chorych leczonych operacyjnie
wykonano jedno- lub obustronne usuni´cie uk∏adu ch∏onnego szyi. Ca∏kowite dawki w przypadku samodzielnej radioterapii
wynios∏y od 30 Gy do 76 Gy, w przypadku pooperacyjnej – od 20 Gy do 60 Gy.
W y n i k i.  Odsetek 3 letniego prze˝ycia bezobjawowego w grupie leczonych metodà skojarzonà wyniós∏ 45%, a w grupie leczo-
nych samodzielnà radioterapià 20% (p=0,028). W 10 przypadkach, po Êrednim okresie obserwacji 39 miesi´cy, nastàpi∏o ujaw-
nienie si´ ogniska pierwotnego – w 8 przypadkach w regonie g∏owy i szyi, w 2 – w obr´bie dolnych dróg oddechowych. Prze˝y-
cie bezobjawowe w grupie chorych z ujawnionym guzem pierwotnym wynios∏o 46%, w porównaniu do pozosta∏ych chorych
– 33% trzyletnich prze˝yç bezobjawowych.
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Head and neck node metastases are frequently the first
symptoms of cancers arising in this anatomical region
(30-40%) [1-3, 6]. Discovering in physical examination
enlarged neck nodes, and then confirmation of malignant
disease by biopsy or histopathological examination of dis-
sected node suggests that occult primary site is located wi-
thin mucosal membrane of upper respiratory, alimentary
tracts or systematic disease (lymphoma). Knowledge of
head and neck region lymphatic drainage and clinical
presentation of tumours arising in this region as well as
cancers of others localisation, makes finding of primary si-
te easier. However there is often a need of more advan-
ced diagnostical workup especially endoscopies and mo-
dern imaging procedures.
There is a high probability of occult infiltration of
pharyngeal mucosal membrane if squamous cell cancer
neck nodes metastases are diagnosed. There are some re-
gions difficult to approach during routine laryngeal exami-
nation: Rosenmüller fossa and the roof of nasopharynx,
base of the tongue and basal part of tonsil in the middle
pharynx, pyriform sinuses and postcricoid area in hypo-
pharynx, and laryngeal vestibules. Each of them is frequen-
tly the „silent” location of arising tumour. Thus in such
clinical situations in many laryngological and oncological
centres modern diagnostic methods are conducted (ie. rhi-
nopharygoscopy with elective biopsy, spiral computer to-
mography and/or magnetic resonance of pharynx, para-
pharyngeal spaces and base of the skull, elective dissec-
tion of soft palate tonsil ipsilateral to the involved nodes),
which frequently discover the occult primary site of tumo-
ur. However in a small proportion of all cases (about 5% of
all head and neck diagnosed metastases), primary site can
not be discovered, in spite of conducting all diagnostic pro-
cedures [1-4, 6]. In such clinical situations individual indica-
tion to oncological treatment should be considered and
the optimal therapeutic strategies should be undertaken.
As far, there is no generally acceptable schedules of
treatment of patients with squamous cell carcinoma disse-
mination to the lymphatic nodes of head and neck. Altho-
ugh the necessity of involved lymphatic nodes dissection is
beyond the doubt [1-6], still several methods of elective or
adjuvant treatment are discussed [1, 2, 5-8].
Since the end of eighties, in Maria Sklodowska-Curie
Memorial Institute of Oncology in Gliwice elective ra-
diotherapy after surgical dissection of metastatic nodes in
cases of cancer of unknown primary site (CUP-syndrome)
is used. This treatment is conducted as conventional irra-
diation of whole head, neck and supraclavicular lympha-
tic nodes, surgically removed nodal bed and mucosal
membrane of whole pharynx, from the base of the skull to
the end of upper part of oesophagus with a total dose of
50-54 Gy given in 25-30 fractions, with eventual dose
escalation to the involved nodal bed and/or clinically „su-
spected” regions of pharynx.
The aim of this work was to evaluate the results of
treatment of patients with squamous cell cancer head
and neck lymphatic nodes metastases from unknown pri-
mary site treated in Institute of Oncology in Gliwice, as
well as the trial to estimate the kinetics of primary tu-
mour site occurring.
Material
Thirty six patients – 33 man and 3 woman with head and neck
lymphatic nodes squamous cell cancer metastases treated be-
tween 1980-95 in Centre of Oncology-Institute in Gliwice were
involved in this study. Median age in group of male was 56 years,
in group of females 57 years (range 27-85 years). All patients we-
re in good or very good general condition (according to
ZUBROD scale: 0-1). Median haemoglobin level was in male
and female group 13,8mg/dl and 13mg/dl respectively.
In all cases the first symptom of disease were enlarged
lymphatic nodes of head and neck region. Time from occurring
the first sign of cancer to the first examination by a specialist ran-
ged from one week to 12 months (median 3 months).
Analysis of topography of involved lymphatic nodes was
performed using the Lindberg nomenclature, which identifies
groups of deep neck nodes: para- and retropharyngeal nodes,
and superficial: submental and submandibular, upper, middle
and lower level in anterior and posterior chain in relation to
sternocleidomastoid muscle.
The most frequent metastases were in upper anterior neck
nodes -16 cases (44.5%). Metastases to the middle and lower an-
terior nodes occurred in 7 (19.5%) and 5 (14%) cases respective-
ly. Single metastases were observed in 28 patients (78%), multi-
ple (to at least two nodes) in 8 cases (22%) (ipsilateral in 5 cases
(14%), contralateral – in 3 8%). In all cases primary tumour
was unknown and T-stage was indicated as Tx. There were10
cases(28%) in N1 stage, 9 (25%) in N2, 16(45%) in N3. In one
patient N stage could have not been estimated. (Tab. I) Combi-
ned treatment was performed in 18 patients (50%), but only in
15 of them (41.5%) with radical intention. With radiotherapy
alone 16 patients (44.5%) were treated, from whom 10 with ra-
dical intention (28%). Only in two cases (5.5%) surgery alone
were performed. In general, surgical treatment consisted of tu-
morectomy (90%), only 10% of patients treated with surgery
underwent uni-or bilateral lymphadenactomy (Tab. II)
Irradiation of whole pharynx and regional lymphatic nodes
– 2 opposed fields extended from base of the skull to the upper
margin of thyroid gland and fields encompassing the supraclavi-
cular lymphatic nodes was used in 13 patients (36%) treated
with irradiation. In remaining patients other radiotherapy tech-
niques were used: portals limited to the involved nodes or nodal
bed, or fields encompassing only one side of the neck. Radiothe-
rapy was performed using γ Co60 irradiation. Posterior neck
nodes after spinal cord exclusion (after median dose 46 Gy) we-
re irradiated with 9 MeV electrons. Supraclavicular lymphatic
nodes were irradiated with γ Co60 photons to the total dose 50
Gy. Total doses ranged from 30 Gy to 76 Gy, but in cases when
radiotherapy was combined with surgery- from 20 Gy to 60 Gy.
Po d s u m o w a n i e.  Przedstawiona analiza wyników leczenia chorych na zespó∏ CUP poÊrednio wskazuje na koniecznoÊç
elektywnego, pooperacyjnego napromieniania zarówno ca∏ego uk∏adu ch∏onnego szyi, jak i b∏on Êluzowych trzech pi´ter
gard∏a i krtani po radykalnym chirurgicznym usuni´ciu przerzutowo zmienionych w´z∏ów ch∏onnych.
Key words: head and neck lymph nodes metastases, CUP-syndrome, unknown primary site, radiotherapy
S∏owa kluczowe: przerzuty do w´z∏ów ch∏onnych, zespó∏ CUP, nieznane ognisko pierwotne, radioterapia
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Tab. I. Clinical stage of involved lymphatic nodes
Clinical stage Lymph node's number of patients
diameter (cm)
N1 1-2 2
>2 8
N2 <4 6
4-5 1
>5 2
N3 <8 4
8-10 7
>10 5
NX - 1
Tab. II. Treatment modalities and early results
Treatment
OP+RT RT OP
No. of patients 18 (50.0%) 16 (44.5%) 2 (5.5%)
Surgery type
tumorectomia 16 (44.0%) -
limfadenectomia 2 (5.5%) -
Technique of RT:
neck lymphatic
system+pharnyx 7 (19.5%) 6 (16.5%) -
tumor bed/tumor 11 (30.5%) 10 (28.0%) -
Total dose of RT:
20-40 Gy 3 (8.0%) 6 (16.5%) -
41-50 Gy 7 (19.5%) 4 (11.0%) -
>50 Gy 8 (22.0%) 6 (16.5%) -
Early results of treatment:
CR 12 (33.0%) 2 (5.5%) -
PR 3 (8.0%) 10 (28.0%) -
NC 3 (8.0%) 4 (11.0%) 2 (5.5%)
Stat ist ical  methods
Statistical analysis were performed using the Kaplan-Meier actu-
arial analysis. Results were evaluated using a Logrank test. As
a criteria of efficiency of treatment 3-year disease free survival
(DFS) was assumed.
Results
Complete regression of involved lymphatic nodes was
observed in 14 cases (39%), partial in 13 cases (36%).
No change in nodes diameter or progression during treat-
ment were noticed in 9 patients (25%).
Generally, in a whole analysed group 3-year DFS
rate was 36% (Fig.1). In a group treated with combined
method (surgery with postoperative radiotherapy) DFS
was 45%. However in group treated with radiotherapy
alone DFS was only 20% (almost in half of those patients
palliative form of treatment was used). The differences
between these two groups were statistically significant
(p=0.0028) (Fig. 2).
Considering the small number of patients treated
with surgery alone (2 cases), this group was not involved
in statistical analysis. One patient died of dissemination of
the disease to the lungs 26 months after surgery, second
was „lost” from observation after 28 months, both of
them had symptoms of the active disease in head and
neck region at that time.
Median disease free survival in group of patients tre-
ated with „large field” technique, encompassing all regio-
nal, head and neck lymphatic nodes (all patients treated
with radical intention) was 39 months, and was almost six
times higher then in group treated with others methods (7
months). Generally in group treated with radical inten-
tion 3 years disease free survival was significantly higher
then in other cases (48% vs 9%, p=0.0002) (Fig. 3).
Fig. 1. Disease free survival in whole group
Fig. 2. Survival curves of groups treated with combined method and ra-
diotherapy alone
Fig. 3. Survival curves of groups of patients treated with radical and
palliative intention
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Revealing of the primary tumour site was observed in
10 cases. Median time from the first symptoms, metasta-
tically changed head and neck nodes, to the primary site
manifestation was 39 months. In 8 cases the primary site
was in head and neck region (in 7 patients within pre-
viously irradiated area), in 2 cases primary tumour was lo-
cated in lungs.
The most frequent primary tumour site in head and
neck region was the tonsil, indicated in 3 of 8 cases. Me-
dian time from lymphatic nodes metastases to the manife-
station of the tumour in this group was 19 months. Treat-
ment of the lymphatic nodes in this patients was perfor-
med using surgery and postoperative radiation therapy-in
2 cases using „large”, in 1 patient using „small”, unilateral
field.
Tonsilectomy was performed in the treatment of the
primary site in all cases, in 1 patient postoperative radio-
therapy was undertaken, using „large” field technique,
to the total dose 60 Gy (re-irradiation). In the following
two patients cancer of the tongue occurred with the me-
dian time of 55 months after the first symptoms. In this
two cases radiotherapy alone was used in the treatment of
the lymphatic nodes to the doses 66 Gy („large fields”),
and 50 Gy („small fields”). Surgery was administrated in
treatment of the primary tumour in one patient, in the se-
cond – chemotherapy was undertaken. In one case, 4
months after neck nodes metastases carcinoma of the na-
sopharynx has been occurring. Because of the poor gene-
ral condition of this patient and advanced stage of disease
symptomatic therapy was administered. In the next pa-
tient the primary tumour was located in the floor of the
mouth, which revealed in 14 months after the end of ra-
diotherapy of involved neck nodes in clinical N3 stage. Al-
so in this case, considering progression of the disease in
lymphatic nodes, symptomatic therapy was used. In the
last patient during 64th month of observation after irra-
diation of the metastatically changed neck nodes in N3
stage, cancer of the larynx has been occurring together
with the lung metastases. In the two cases of the remote
lung cancer palliative form of radiotherapy was used.
Generally in group of patients with manifested pri-
mary tumour 46% of disease free survival was indicated,
in comparison to the other patients – 33% of 3 years
DFS.
Discussion
Notwithstanding that the cases of squamous cell cancer
metastases from occult primary site to the head and neck
lymph node are very rare, this problem is a point of inte-
rest of relative large number of publications. In majority
of them importance of combined treatment of CUP-syn-
drome is emphasised [1-7]. However the majority of stu-
dies deal with cases treated during many years with rela-
tive inhomogenity of clinical material, as well as a small
number of analysed groups. These factors do not let to
draw the univocal conclusions. Also present study concern
inhomogeneous group of patients. The reason of a wide,
fifteen years, period of enrolment of the clinical mate-
rial was based more on the irradiation of patients using
megavoltage rays, than on uniform method of treatment,
which was introduced into clinical practice during only
just last 5 years (1990-95).
Since the beginning of 90’s in Institute of Oncology
in Gliwice in most patients with squamous cell cancer
metastases from occult primary site, surgical dissection of
involved neck node or nodes and postoperative radio-
therapy of neck and supraclavicular lymphatic system as
well as all levels of pharynx is recommended. 
Surgery gives opportunity to microscopy examina-
tion of involved nodes, to define histopatological type of
cancer and the presence of extracapsular invasion of the
tumour. This last factor, prognostically especially impor-
tant, as Strojan et all has shown, is certainly an indication
to postoperative radiotherapy [4].
Postoperative irradiation of whole head and neck
lymphatic system, as Jesse et al. has proved, could signifi-
cantly decrease the risk of recurrence in the regional no-
des at operated and opposite side of neck [1].
Almost all last published studies emphasizes signifi-
cance of elective irradiation of whole pharyngeal mucosal
membrane in CUP-syndrome treatment [2, 4, 7, 8]. For
example Carlson et al. has observed, that 5 year disease
free survival in group of patients with whole head and
neck lymphatic system and mucosal membrane of all le-
vels of pharynx irradiated approached 47% and was signi-
ficantly, almost 2 times higher than in a group of patients
irradiated using others, less radical techniques [7]. Such
form of combined treatment of CUP-syndrome was admi-
nistrated in our analysed material only in 8, treated during
last five years, patients and almost 5 times longer disease
free survival in this group was observed.
Harper et al [8] has shown that elective radiotherapy
significantly reduces risk of primary tumour occurring in
irradiated volume. The risk is about 10-15% for 5 year of
observation and it does not differ from the risk of the
new cancer occurring in the previously irradiated volume
of mucosal membrane during radiotherapy of tonsil or
a pharyngeal tumours.
The occurring of a primary tumour after treatment
seems to be the separate problem. It is deal with 11% to
54% of patients with CUP- syndrome [1, 2, 4-8]and consi-
derably more often primary tumour occur after surgery
alone (about 30% of cases) than after combined treat-
Fig. 4. Survival in groups with occurred and hidden  primary sit
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ment or radiotherapy alone (6% and 15% of cases re-
spectively).
An interesting problem seems to be a relative worst
prognosis connected with primary site occurring (only
46% of 3 years DFS). Probably, in analysed material it is
connected with an advanced clinical stages of primary tu-
mours at the moment of the diagnose. In Kruk-Zagajew-
ska et al. analysis, 3 year disease free survival was even lo-
wer, and ranged 30%. However the most important seems
to be the thesis proposed in this study. They proposed
an aggressive metastatic behaviour of occulted primaries,
which makes radical treatment impossible.
Conclusions
The results of our study indirectly suggest the need for
complementary, elective irradiation of the whole lym-
phatic drainage of the head and neck region, as well as
the entire pharynx, postoperatively.
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